tetano
Editor, Senior Moderator
J Clin Med
. 2023 Feb 2;12(3):1197.
doi: 10.3390/jcm12031197.
Prognostic Role of Monocyte Distribution Width, CRP, Procalcitonin and Lactate as Sepsis Biomarkers in Critically Ill COVID-19 Patients
Dejana Bajić[SUP] 1 [/SUP], Jovan Matijašević[SUP] 2 3 [/SUP], Ljiljana Andrijević[SUP] 1 [/SUP], Bojan Zarić[SUP] 2 3 [/SUP], Mladena Lalić-Popović[SUP] 4 [/SUP], Ilija Andrijević[SUP] 2 3 [/SUP], Nemanja Todorović[SUP] 4 [/SUP], Andrea Mihajlović[SUP] 5 [/SUP], Borislav Tapavički[SUP] 5 [/SUP], Jelena Ostojić[SUP] 3 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic and one group of patients has developed a severe form of COVID-19 pneumonia with an urgent need for hospitalization and intensive care unit (ICU) admission. The aim of our study was to evaluate the prognostic role of MDW, CRP, procalcitonin (PCT), and lactate in critically ill COVID-19 patients. The primary outcome of interest is the 28 day mortality of ICU patients with confirmed SARS-CoV-2 infection and sepsis (according to Sepsis 3 criteria with acute change in SOFA score ≥ 2 points). Patients were divided into two groups according to survival on the 28th day after admission to the ICU. Every group was divided into two subgroups (women and men). Nonparametric tests (Mann-Whitney) for variables age, PCT, lactate, and MDW were lower than alpha p < 0.05, so there was a significant difference between survived and deceased patients. The Chi-square test confirmed statistically significant higher values of MDW and lactate in the non-survivor group. We found a significant association between MDW, lactate, procalcitonin, and fatal outcome, higher values were reported in the deceased group.
Keywords: COVID-19; SARS-CoV-2; biomarker; monocyte distribution width; mortality; sepsis.
. 2023 Feb 2;12(3):1197.
doi: 10.3390/jcm12031197.
Prognostic Role of Monocyte Distribution Width, CRP, Procalcitonin and Lactate as Sepsis Biomarkers in Critically Ill COVID-19 Patients
Dejana Bajić[SUP] 1 [/SUP], Jovan Matijašević[SUP] 2 3 [/SUP], Ljiljana Andrijević[SUP] 1 [/SUP], Bojan Zarić[SUP] 2 3 [/SUP], Mladena Lalić-Popović[SUP] 4 [/SUP], Ilija Andrijević[SUP] 2 3 [/SUP], Nemanja Todorović[SUP] 4 [/SUP], Andrea Mihajlović[SUP] 5 [/SUP], Borislav Tapavički[SUP] 5 [/SUP], Jelena Ostojić[SUP] 3 [/SUP]
Affiliations
- PMID: 36769843
- DOI: 10.3390/jcm12031197
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic and one group of patients has developed a severe form of COVID-19 pneumonia with an urgent need for hospitalization and intensive care unit (ICU) admission. The aim of our study was to evaluate the prognostic role of MDW, CRP, procalcitonin (PCT), and lactate in critically ill COVID-19 patients. The primary outcome of interest is the 28 day mortality of ICU patients with confirmed SARS-CoV-2 infection and sepsis (according to Sepsis 3 criteria with acute change in SOFA score ≥ 2 points). Patients were divided into two groups according to survival on the 28th day after admission to the ICU. Every group was divided into two subgroups (women and men). Nonparametric tests (Mann-Whitney) for variables age, PCT, lactate, and MDW were lower than alpha p < 0.05, so there was a significant difference between survived and deceased patients. The Chi-square test confirmed statistically significant higher values of MDW and lactate in the non-survivor group. We found a significant association between MDW, lactate, procalcitonin, and fatal outcome, higher values were reported in the deceased group.
Keywords: COVID-19; SARS-CoV-2; biomarker; monocyte distribution width; mortality; sepsis.